Fig. 1From: Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patientsBlood samples were drawn at baseline before neoadjuvant chemotherapy (NA1), after 2 cycles of anthracycline-containing chemotherapy (NA2), at the end of the chemotherapy 8 days before surgery (D8) and 3 months after the surgery (3 M)Back to article page